Robin Prince

Principal investigator.

Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$6.8MFederal grants as PI14 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20212026
AwardsPatents
Federal awards as principal investigator

14 awards · $6.8M

DateAgencyAwardAmountCompany
Sep 8, 2026NIHSBIR Phase II
AstroTarget™ Astro-Enrichment Kit: A Microfluidic-Free Platform for High-Throughput Rare-Astrocyte Isolation and Multi-Omic Profiling from Frozen Alzheimer’s Brain
$506K—
Aug 27, 2026NIHSBIR Phase II
FIND-seq: A Novel Cell Sorting Technology to Enable Investigation of Rare Cells in Primary Human Tissues
$1.0M—
Aug 20, 2026NIHSBIR Phase II
A Universal Platform for Ultrahigh-Throughput Biocatalyst Evolution With micro-Mass Spectrometry
$1.0M—
Aug 19, 2026NIHSBIR Phase II
Spatially Resolved Single-Cell DNA Sequencing: A General Spatial Genomics Platform with Application to HIV Reservoir Mapping
$300K—
Aug 19, 2026NIHSBIR Phase II
HIVE-seq: A Novel Omics Technology to Profile Thousands of Single HIV-Positive Cells
$307K—
Aug 7, 2026NIHSBIR Phase II
Ultrahigh-Throughput Cell Interaction Screening to Advance CAR-T Therapeutic Development
$307K—
Aug 4, 2026NIHSBIR Phase II
Integrated High-Throughput Microfluidic-Mass Spectrometry for Enhanced Biomedical Data Generation and AI Model Training
$300K—
Sep 12, 2025NIHSBIR Phase II
FIND-seq: A Novel Cell Sorting Technology to Enable Investigation of Rare Cells in Primary Human Tissues
$307K—
Jul 21, 2025NIHSBIR Phase II
A Universal Platform for Ultrahigh-Throughput Biocatalyst Evolution With micro-Mass Spectrometry
$307K—
Apr 1, 2024NIHSBIR Phase I
Point-of-care viral load monitoring to support large-scale clinical testing of new HIV cure strategies
$268K—
Jan 31, 2024NIHSBIR Phase I
Single cell tri-omics: High coverage simultaneous profiling of DNA, RNA, and proteins in single cells
$268K—
Sep 19, 2023NIHSTTR Phase II
A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution
$817K—
Sep 16, 2022NIHSTTR Phase II
A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution
$838K—
Sep 24, 2021NIHSTTR Phase I
Ultrahigh Throughput Microscale Mass Spectrometry for Pharmaceutical Prenylation Enzyme Engineering
$254K—
Among 1,601 researchers in this sector

Peer ranks

Federal funding#34
Awards as PI#24
Patents#27
From filings, awards and patents

Companies

No tracked company linked yet.

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.